| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ADA
|
adenosine deaminase
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
ALAS2
|
5'-aminolevulinate synthase 2
|
|
ALOX5AP
|
arachidonate 5-lipoxygenase-activating protein
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMPD1
|
adenosine monophosphate deaminase 1
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AR
|
androgen receptor
|
|
ARL15
|
ADP-ribosylation factor-like 15
|
|
AURKC
|
aurora kinase C
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C5
|
complement component 5
|
|
CAP1
|
CAP, adenylate cyclase-associated protein 1 (yeast)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle)
|
|
CCHCR1
|
coiled-coil alpha-helical rod protein 1
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD14
|
CD14 molecule
|
|
CD209
|
CD209 molecule
|
|
CD33
|
CD33 molecule
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CIRH1A
|
cirrhosis, autosomal recessive 1A (cirhin)
|
|
CLN6
|
ceroid-lipofuscinosis, neuronal 6, late infantile, variant
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP4F2
|
cytochrome P450, family 4, subfamily F, polypeptide 2
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DMD
|
dystrophin
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DOK5
|
docking protein 5
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DRD1
|
dopamine receptor D1
|
|
DRD2
|
dopamine receptor D2
|
|
DRD4
|
dopamine receptor D4
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ENPP1
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAM161A
|
family with sequence similarity 161, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FECH
|
ferrochelatase
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABRA6
|
gamma-aminobutyric acid (GABA) A receptor, alpha 6
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2
|
|
GBA
|
glucosidase, beta, acid
|
|
GBA2
|
glucosidase, beta (bile acid) 2
|
|
GGCX
|
gamma-glutamyl carboxylase
|
|
GIGYF2
|
GRB10 interacting GYF protein 2
|
|
GJB2
|
gap junction protein, beta 2, 26kDa
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GOLM1
|
golgi membrane protein 1
|
|
GOSR2
|
golgi SNAP receptor complex member 2
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HFE
|
hemochromatosis
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB3
|
major histocompatibility complex, class II, DR beta 3
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KITLG
|
KIT ligand
|
|
LCT
|
lactase
|
|
LDLR
|
low density lipoprotein receptor
|
|
LEPR
|
leptin receptor
|
|
LHX6
|
LIM homeobox 6
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LMNA
|
lamin A/C
|
|
LRAT
|
lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTA
|
lymphotoxin alpha
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC3R
|
melanocortin 3 receptor
|
|
MC4R
|
melanocortin 4 receptor
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSTN
|
myostatin
|
|
MT-TS1
|
tRNA
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUTYH
|
mutY homolog
|
|
MYH8
|
myosin, heavy chain 8, skeletal muscle, perinatal
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NEUROG3
|
neurogenin 3
|
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies)
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOL11
|
nucleolar protein 11
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPA
|
natriuretic peptide A
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
|
NRG1
|
neuregulin 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PACRG
|
PARK2 co-regulated
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PAX6
|
paired box 6
|
|
PGR
|
progesterone receptor
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
PON1
|
paraoxonase 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PTGDR
|
prostaglandin D2 receptor (DP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RFXANK
|
regulatory factor X-associated ankyrin-containing protein
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNLS
|
renalase, FAD-dependent amine oxidase
|
|
RP2
|
retinitis pigmentosa 2 (X-linked recessive)
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
SCN1A
|
sodium channel, voltage gated, type I alpha subunit
|
|
SEPT9
|
septin 9
|
|
SGCG
|
sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein)
|
|
SIRT1
|
sirtuin 1
|
|
SLC25A20
|
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20
|
|
SLC6A19
|
solute carrier family 6 (neutral amino acid transporter), member 19
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPINK7
|
serine peptidase inhibitor, Kazal type 7 (putative)
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
STX11
|
syntaxin 11
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TBX22
|
T-box 22
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TMC1
|
transmembrane channel-like 1
|
|
TMPRSS11A
|
transmembrane protease, serine 11A
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TP53
|
tumor protein p53
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
